century

DaVita, PayPal, Century Communities, Berry Global and Turning Point Brands

For Immediate Release

Chicago, IL – August 6, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: DaVita Inc. DVA, PayPal Holdings, Inc. PYPL, Century Communities, Inc. CCS, Berry Global Group, Inc. BERY and Turning Point Brands, Inc. TPB.

Here are highlights from Wednesday’s Analyst Blog:

Buy These 5 Stocks Before It’s Too Late

Earnings season is a great time to dive into stocks because there’s a certain amount of certainty that comes from all the related discussions.

This is when our expectations about the just-concluded quarter are met, exceeded or missed. It’s also when we get a somewhat clearer picture about the next quarter and at times, also the year. So jumping into stocks that have announced resounding beats

Read More

How scientists revived an old-school treatment for a 21st century pandemic

Dr. Arturo Casadevall, a microbiologist and physician at Johns Hopkins University, has spearheaded a nationwide initiative to test the healing powers of "convalescent plasma" from COVID-19 survivors. <span class="copyright">(Kirk McKoy / Los Angeles Times)</span>
Dr. Arturo Casadevall, a microbiologist and physician at Johns Hopkins University, has spearheaded a nationwide initiative to test the healing powers of “convalescent plasma” from COVID-19 survivors. (Kirk McKoy / Los Angeles Times)

A few weeks after the new coronavirus arrived on U.S. shores, Dr. Arturo Casadevall hatched a plan to beat back the outbreak with a medical advance so powerful it had earned a Nobel Prize.

In 1901.

That’s when Dr. Emil Adolf von Behring was honored for pioneering the use of so-called convalescent serum as a treatment for diphtheria. In 1892, the Prussian bacteriologist infected horses with the pathogen that causes the deadly disease. If the beasts recovered, Von Behring harvested their blood, removed its red blood cells and clotting proteins, and introduced the resulting antibody-rich fluid into the bloodstreams of human diphtheria patients.

Until a diphtheria vaccine came into broad use in the 1930s, Von Behring’s daring

Read More